WHO
Launch of 2.3(c) Committee: Salle XXV (Palais des Nations): May 19, 13:00 to 14:30
Submitted by thiru on 17. May 2010 - 3:44On Wednesday, 19 May 2010, the launch of the 2.3(c) Committee will take place at Room XXV of the Palais de Nations from 13:00 to 14:30. Element 2.3(c) of the WHO Global Strategy on Public Health, Innovation and Intellectual Property states:
encourage further exploratory discussions on the utility of possible instruments or mechanisms for essential health and biomedical R&D, including inter alia, an essential health and biomedical R&D treaty
WHO donors (US, Gates Foundation, UK, Norway, Canada, EC, GAVI and Roche): Setting the agenda for global public health?
Submitted by thiru on 15. May 2010 - 5:25As the 63rd World Health Assembly (WHA) opens on May 17, 2010, WHO member countries will meet to consider matters of great moment including such topics as 'counterfeit medical products', pandemic influenza preparedness (sharing of influenza viruses and access to vaccines and other benefits) and the Report of the WHO Expert Working Group on R&D Financing.
WHO report on method of work of the governing bodies
Submitted by thiru on 22. January 2010 - 4:56Friday, 22 January 2010
The 126th session of the Executive Board (EB) of the World Health Organization has deliberated over a Report by the WHO Secretariat entitled "Method of work of the governing bodies" (EB126/26) "has taken note of the report".
Here are some choice excerpts from the report.
Dec 9, 2009 Wikileaks documents related to the WHO EWG
Submitted by Malini Aisola on 21. January 2010 - 9:30On December 9, 2009, Wikileaks posted five sensitive documents related to the WHO Expert Working Group (EWG) on R&D Financing:
a non-public draft report of the WHO EWG a non-public Comparative Analysis done by the EWG the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Overview of the EWG Comparative Analysis an IFPMA summary slide on the EWG Draft Report
Bolivian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property
Submitted by thiru on 20. January 2010 - 0:07This is the statement that the Government of Bolivia delivered on January 19, 2010 at the 126th session of the WHO Executive Board public health, innovation and intellectual property including their views on the EWG process and the Executive Summary of the WHO Expert Working Group on R&D Financing.
The heart of Bolivia's intervention is encapsulated in the penultimate paragraph of their intervention.
World Health Organization (WHO) to hold consultation on report of Expert Working Group on R&D financing
Submitted by KEI Staff on 19. January 2010 - 12:14At the end of a dramatic debate that began yesterday, the Executive Board (EB) of the World Health Organization (WHO) agreed to hold a special consultation on the report of the WHO Expert Working Group (EWG) on R&D Financing. A face-to-face meeting will be held on May 13, a few days before the 63rd WHA begins on 17 May. There will also be opportunities for web submissions on the EWG report. In addition, Dr.
Open Letter to the WHO EB from Cecilia López Montaño, EWG member
Submitted by Malini Aisola on 17. January 2010 - 20:54The following is a letter sent by Cecilia López Montaño, a member of the WHO Expert Working Group on R&D Financing to the WHO Executive Board:
Bogotá. Colombia. January 15th 2010
Dear members of the Executive Board:
I am Cecilia López Montaño, senator of the Colombian Congress and member of the Expert Working Group on Research and Development Financing of the World Health Organization, in representation of the point of view of developing countries, I assume.
A closer look at the WHO EWG endorsed proposals on funding product development partnerships
Submitted by Malini Aisola on 14. January 2010 - 7:04The World Health Organization's Expert Working Group on R&D Financing spent scant attention on how to raise money, but showed considerable interest in how to spend it. The clear favorite approach is to give grants to product development partnerships -- the approach that has now become the most conventional approach, and one not surprisingly endorsed by the PDPs themselves, and also by the Gates Foundation and the IFPMA -- two groups that are often seen as devoted to protecting the status quo in terms of intellectual property and business models for innovation.
Wikileaks reports on IFPMA infiltration of WHO Expert Working Group on R&D Financing
Submitted by thiru on 9. December 2009 - 4:11On Tuesday, December 8, 2009 at 10:42PM (EST), the site Wikileaks, posted this pithy entry on Twitter: "Big Pharma infiltrates WHO Expert Working Group process; WikiLeaks infiltrates Big Pharma".
